Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and thrombolysis 2019-11, Vol.48 (4), p.539-541 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 541 |
---|---|
container_issue | 4 |
container_start_page | 539 |
container_title | Journal of thrombosis and thrombolysis |
container_volume | 48 |
creator | Fatani, Nayyra Fanikos, Christopher Ting, Clara Buckley, Leo F. Fanikos, John |
description | |
doi_str_mv | 10.1007/s11239-019-01925-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2268575473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2268575473</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-bc19ce7629175c2ec137491d31ca958035a2571454d68b98d190d4668f2127e83</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMoun78AQ9S8OKlmpk0TXIU8RNFDwp6Cmk61chuq8ku4r837voBHjyESZhn3gwPY9vA94FzdZAAUJiSw_ygLNUSG4FUolQV3i-zETdoSim4XGPrKT1zzo3huMrWBAilTC1H7OIuUTF0xQ0-ABahfwpNmA4xFW4y9I_FFbXBu9AWDfXUBR9cDJTya_pG1BfIuS5c3-YL6E220rlxoq2vusHuTo5vj87Ky-vT86PDy9ILrKdl48F4UjUaUNIj-bxLZaAV4J2RmgvpUCqoZNXWujG6BcPbqq51h4CKtNhge4vclzi8zihN7SQkT-Ox62mYJYtYa6lkpURGd_-gz8Ms9nm7OQVco64yhQvKxyGlSJ19iWHi4rsFbj9N24Vpmy3buWmr8tDOV_SsmVD7M_KtNgNiAaTc6h8p_v79T-wHTi-EDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2268108284</pqid></control><display><type>article</type><title>Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018</title><source>MEDLINE</source><source>SpringerLink</source><creator>Fatani, Nayyra ; Fanikos, Christopher ; Ting, Clara ; Buckley, Leo F. ; Fanikos, John</creator><creatorcontrib>Fatani, Nayyra ; Fanikos, Christopher ; Ting, Clara ; Buckley, Leo F. ; Fanikos, John</creatorcontrib><identifier>ISSN: 0929-5305</identifier><identifier>EISSN: 1573-742X</identifier><identifier>DOI: 10.1007/s11239-019-01925-7</identifier><identifier>PMID: 31377965</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Cardiology ; Female ; Hematology ; Humans ; Male ; Medicaid ; Medicaid - trends ; Medicine ; Medicine & Public Health ; Middle Aged ; Purinergic P2Y Receptor Antagonists - therapeutic use ; Receptors, Purinergic P2Y12 - drug effects ; Retrospective Studies ; United States</subject><ispartof>Journal of thrombosis and thrombolysis, 2019-11, Vol.48 (4), p.539-541</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Journal of Thrombosis and Thrombolysis is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-bc19ce7629175c2ec137491d31ca958035a2571454d68b98d190d4668f2127e83</cites><orcidid>0000-0003-1570-1486</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11239-019-01925-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11239-019-01925-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31377965$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fatani, Nayyra</creatorcontrib><creatorcontrib>Fanikos, Christopher</creatorcontrib><creatorcontrib>Ting, Clara</creatorcontrib><creatorcontrib>Buckley, Leo F.</creatorcontrib><creatorcontrib>Fanikos, John</creatorcontrib><title>Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018</title><title>Journal of thrombosis and thrombolysis</title><addtitle>J Thromb Thrombolysis</addtitle><addtitle>J Thromb Thrombolysis</addtitle><subject>Adult</subject><subject>Cardiology</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Male</subject><subject>Medicaid</subject><subject>Medicaid - trends</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Purinergic P2Y Receptor Antagonists - therapeutic use</subject><subject>Receptors, Purinergic P2Y12 - drug effects</subject><subject>Retrospective Studies</subject><subject>United States</subject><issn>0929-5305</issn><issn>1573-742X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kE1LxDAQhoMoun78AQ9S8OKlmpk0TXIU8RNFDwp6Cmk61chuq8ku4r837voBHjyESZhn3gwPY9vA94FzdZAAUJiSw_ygLNUSG4FUolQV3i-zETdoSim4XGPrKT1zzo3huMrWBAilTC1H7OIuUTF0xQ0-ABahfwpNmA4xFW4y9I_FFbXBu9AWDfXUBR9cDJTya_pG1BfIuS5c3-YL6E220rlxoq2vusHuTo5vj87Ky-vT86PDy9ILrKdl48F4UjUaUNIj-bxLZaAV4J2RmgvpUCqoZNXWujG6BcPbqq51h4CKtNhge4vclzi8zihN7SQkT-Ox62mYJYtYa6lkpURGd_-gz8Ms9nm7OQVco64yhQvKxyGlSJ19iWHi4rsFbj9N24Vpmy3buWmr8tDOV_SsmVD7M_KtNgNiAaTc6h8p_v79T-wHTi-EDQ</recordid><startdate>20191101</startdate><enddate>20191101</enddate><creator>Fatani, Nayyra</creator><creator>Fanikos, Christopher</creator><creator>Ting, Clara</creator><creator>Buckley, Leo F.</creator><creator>Fanikos, John</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1570-1486</orcidid></search><sort><creationdate>20191101</creationdate><title>Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018</title><author>Fatani, Nayyra ; Fanikos, Christopher ; Ting, Clara ; Buckley, Leo F. ; Fanikos, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-bc19ce7629175c2ec137491d31ca958035a2571454d68b98d190d4668f2127e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Cardiology</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Male</topic><topic>Medicaid</topic><topic>Medicaid - trends</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Purinergic P2Y Receptor Antagonists - therapeutic use</topic><topic>Receptors, Purinergic P2Y12 - drug effects</topic><topic>Retrospective Studies</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fatani, Nayyra</creatorcontrib><creatorcontrib>Fanikos, Christopher</creatorcontrib><creatorcontrib>Ting, Clara</creatorcontrib><creatorcontrib>Buckley, Leo F.</creatorcontrib><creatorcontrib>Fanikos, John</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thrombosis and thrombolysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fatani, Nayyra</au><au>Fanikos, Christopher</au><au>Ting, Clara</au><au>Buckley, Leo F.</au><au>Fanikos, John</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018</atitle><jtitle>Journal of thrombosis and thrombolysis</jtitle><stitle>J Thromb Thrombolysis</stitle><addtitle>J Thromb Thrombolysis</addtitle><date>2019-11-01</date><risdate>2019</risdate><volume>48</volume><issue>4</issue><spage>539</spage><epage>541</epage><pages>539-541</pages><issn>0929-5305</issn><eissn>1573-742X</eissn><cop>New York</cop><pub>Springer US</pub><pmid>31377965</pmid><doi>10.1007/s11239-019-01925-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0003-1570-1486</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0929-5305 |
ispartof | Journal of thrombosis and thrombolysis, 2019-11, Vol.48 (4), p.539-541 |
issn | 0929-5305 1573-742X |
language | eng |
recordid | cdi_proquest_miscellaneous_2268575473 |
source | MEDLINE; SpringerLink |
subjects | Adult Cardiology Female Hematology Humans Male Medicaid Medicaid - trends Medicine Medicine & Public Health Middle Aged Purinergic P2Y Receptor Antagonists - therapeutic use Receptors, Purinergic P2Y12 - drug effects Retrospective Studies United States |
title | Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T10%3A21%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Use%20of%20P2Y12%20inhibitors%20among%20Medicaid%20beneficiaries%20between%202008%20and%202018&rft.jtitle=Journal%20of%20thrombosis%20and%20thrombolysis&rft.au=Fatani,%20Nayyra&rft.date=2019-11-01&rft.volume=48&rft.issue=4&rft.spage=539&rft.epage=541&rft.pages=539-541&rft.issn=0929-5305&rft.eissn=1573-742X&rft_id=info:doi/10.1007/s11239-019-01925-7&rft_dat=%3Cproquest_cross%3E2268575473%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2268108284&rft_id=info:pmid/31377965&rfr_iscdi=true |